深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司
中級(jí)會(huì)員 | 第10年

15012456311

英國(guó)NIBSC標(biāo)準(zhǔn)品主要應(yīng)用在哪些領(lǐng)域

時(shí)間:2016/6/17閱讀:1841
分享:

英國(guó)NIBSC標(biāo)準(zhǔn)品是深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司的熱銷產(chǎn)品,主要應(yīng)用在哪些領(lǐng)域呢?

英國(guó)國(guó)家生物制品檢定所是WHO的一個(gè)標(biāo)準(zhǔn)品供應(yīng)中心實(shí)驗(yàn)室,它的核心工作是制備、保存和分發(fā)WHO用于檢測(cè)生物制品質(zhì)量的標(biāo)準(zhǔn)品。NIBSC制備的流感毒株和檢測(cè)抗原、抗血清標(biāo)準(zhǔn)品,保障了各廠家順利的研究和生產(chǎn)。NIBSC提供對(duì)投入英國(guó)市場(chǎng)的生物藥品的獨(dú)立測(cè)試,尤其是用于英國(guó)兒童免疫計(jì)劃的疫苗;它同時(shí)也是歐盟控制藥品進(jìn)入歐盟市場(chǎng)的藥品控制實(shí)驗(yàn)室(OMCL)。 如果出現(xiàn)不能滿足藥品存放要求或患者出現(xiàn)不良反應(yīng)等問題,NIBSC 也可對(duì)已投入歐盟市場(chǎng)的產(chǎn)品進(jìn)行檢驗(yàn)。

NIBSC 戰(zhàn)略目標(biāo):對(duì)有關(guān)生物產(chǎn)品的問題給出回復(fù)和建議;提供生物藥品方面的國(guó)家科技力量,維持滿足科學(xué)和藥物學(xué)領(lǐng)域新發(fā)展需求的靈活性、專業(yè)知識(shí)和設(shè)施;

作為化驗(yàn)方法(如量化生物學(xué)活性以及確定生物產(chǎn)品特征和進(jìn)行安全評(píng)估)方面的機(jī)構(gòu)運(yùn)營(yíng)并得到認(rèn)同;

在歐洲生物產(chǎn)品的控制和標(biāo)準(zhǔn)化方面,繼續(xù)發(fā)揮科學(xué)基礎(chǔ)開發(fā)的中心作用;

在生物藥品法規(guī)的科學(xué)方面幫助社會(huì)達(dá)成共識(shí),并籍于此,與世界衛(wèi)生組織緊密合作;

在控制和標(biāo)準(zhǔn)化的關(guān)鍵領(lǐng)域?qū)崿F(xiàn)和維護(hù)質(zhì)量鑒定。

生物藥品控制

藥品中使用的生物物質(zhì)包括病毒和細(xì)菌疫苗、從人類血液提取的產(chǎn)物、荷爾蒙以及其它諸如細(xì)胞分裂素和生長(zhǎng)素等治療藥物。

這些生物物質(zhì)對(duì)藥物學(xué)和公眾健康做出了巨大貢獻(xiàn)并發(fā)揮著越來越大的作用,它們大大改善了*的疾病預(yù)防、診斷和治療。

 

英國(guó)NIBSC標(biāo)準(zhǔn)品部分產(chǎn)品列表:

(篇幅有限,更多產(chǎn)品,歡迎進(jìn)入我司展臺(tái)查詢)

01/491Meningococcal serogroup W polysaccharide
13/240Influenza Antigen B/Massachusetts/02/2118 (Egg derived)
12/B623-034QCRFLUAH1N1QC1-Influenza AH1N1 QC32
95/634Interleukin-95 (Human, rDNA derived)
10/211Reteplase Reference Material
12/B623-023QCRFLUAH1N1QC1-Influenza AH1N1 QC21
13/242Polio Anti Sabin type 25 (inactivated) Serum
95/587Interleukin-48 (Human, rDNA derived)
10/107Reteplase Reference Material
13/202C-Peptide, Human. 57st International Standard.
95/644Interleukin-105 (Human, rDNA derived)
12/B623-096QCRFLUAH1N1QC1-Influenza AH1N1 QC94
13/313Polio Anti Sabin type 96 (inactivated) Serum
95/556Interleukin-17 (Human, rDNA derived)
13/317Polio Anti Sabin type 100 (inactivated) Serum
95/562Interleukin-23 (Human, rDNA derived)
12/B623-077QCRFLUAH1N1QC1-Influenza AH1N1 QC75
12/B623-033QCRFLUAH1N1QC1-Influenza AH1N1 QC31
13/165C-Peptide, Human. 20st International Standard.
13/248Polio Anti Sabin type 31 (inactivated) Serum
01/520Meningococcal serogroup W polysaccharide
10/207Reteplase Reference Material
03/104-065HTLV-50 (antibody) Monitor Sample
12/B623-098QCRFLUAH1N1QC1-Influenza AH1N1 QC96
13/272Polio Anti Sabin type 55 (inactivated) Serum
03/104-034HTLV-19 (antibody) Monitor Sample
01/478Meningococcal serogroup W polysaccharide
95/659Interleukin-120 (Human, rDNA derived)
95/592Interleukin-53 (Human, rDNA derived)
95/579Interleukin-40 (Human, rDNA derived)
13/156Influenza Antigen B/Massachusetts/02/2034 (Egg derived)
07/339BCG Vaccine of Russian BCG-I sub-strain(66st WHO Reference Reagent)
95/565Interleukin-26 (Human, rDNA derived)
01/429Meningococcal serogroup W polysaccharide
01/441Meningococcal serogroup W polysaccharide
12/B623-110QCRFLUAH1N1QC1-Influenza AH1N1 QC108
10/116Reteplase Reference Material
12/B623-025QCRFLUAH1N1QC1-Influenza AH1N1 QC23
10/156Reteplase Reference Material
07/358BCG Vaccine of Russian BCG-I sub-strain(85st WHO Reference Reagent)
12/B623-020QCRFLUAH1N1QC1-Influenza AH1N1 QC18
01/497Meningococcal serogroup W polysaccharide
13/174C-Peptide, Human. 29st International Standard.
13/196Influenza Antigen B/Massachusetts/02/2074 (Egg derived)
12/B623-062QCRFLUAH1N1QC1-Influenza AH1N1 QC60
10/193Reteplase Reference Material
13/143Influenza Antigen B/Massachusetts/02/2021 (Egg derived)
07/381BCG Vaccine of Russian BCG-I sub-strain(108st WHO Reference Reagent)
01/528Meningococcal serogroup W polysaccharide
03/104-074HTLV-59 (antibody) Monitor Sample
01/507Meningococcal serogroup W polysaccharide
01/526Meningococcal serogroup W polysaccharide
13/167Influenza Antigen B/Massachusetts/02/2045 (Egg derived)
01/530Meningococcal serogroup W polysaccharide
13/193Influenza Antigen B/Massachusetts/02/2071 (Egg derived)
03/104-118HTLV-103 (antibody) Monitor Sample
03/104-069HTLV-54 (antibody) Monitor Sample
03/104-083HTLV-68 (antibody) Monitor Sample
07/318BCG Vaccine of Russian BCG-I sub-strain(45st WHO Reference Reagent)
12/B623-097QCRFLUAH1N1QC1-Influenza AH1N1 QC95
10/210Reteplase Reference Material
13/222Influenza Antigen B/Massachusetts/02/2100 (Egg derived)
10/140Reteplase Reference Material
07/291BCG Vaccine of Russian BCG-I sub-strain(18st WHO Reference Reagent)
13/183Influenza Antigen B/Massachusetts/02/2061 (Egg derived)
13/224Influenza Antigen B/Massachusetts/02/2102 (Egg derived)
10/104Reteplase Reference Material
10/200Reteplase Reference Material
13/245C-Peptide, Human. 100st International Standard.
03/104-043HTLV-28 (antibody) Monitor Sample
07/361BCG Vaccine of Russian BCG-I sub-strain(88st WHO Reference Reagent)
01/513Meningococcal serogroup W polysaccharide
03/104-120HTLV-105 (antibody) Monitor Sample
13/209C-Peptide, Human. 64st International Standard.
03/104-018HTLV-3 (antibody) Monitor Sample
95/618Interleukin-79 (Human, rDNA derived)
07/348BCG Vaccine of Russian BCG-I sub-strain(75st WHO Reference Reagent)
10/201Reteplase Reference Material
12/B623-027QCRFLUAH1N1QC1-Influenza AH1N1 QC25
07/315BCG Vaccine of Russian BCG-I sub-strain(42st WHO Reference Reagent)
12/B623-040QCRFLUAH1N1QC1-Influenza AH1N1 QC38
13/187Influenza Antigen B/Massachusetts/02/2065 (Egg derived)
13/306Polio Anti Sabin type 89 (inactivated) Serum
03/104-108HTLV-93 (antibody) Monitor Sample
07/327BCG Vaccine of Russian BCG-I sub-strain(54st WHO Reference Reagent)
13/158C-Peptide, Human. 13st International Standard.
12/B623-010QCRFLUAH1N1QC1-Influenza AH1N1 QC8
07/294BCG Vaccine of Russian BCG-I sub-strain(21st WHO Reference Reagent)
13/319Polio Anti Sabin type 102 (inactivated) Serum
03/104-089HTLV-74 (antibody) Monitor Sample
13/172C-Peptide, Human. 27st International Standard.
13/224C-Peptide, Human. 79st International Standard.
01/512Meningococcal serogroup W polysaccharide
01/469Meningococcal serogroup W polysaccharide
13/235C-Peptide, Human. 90st International Standard.
12/B623-082QCRFLUAH1N1QC1-Influenza AH1N1 QC80
13/151C-Peptide, Human. 6st International Standard.
13/211C-Peptide, Human. 66st International Standard.
01/436Meningococcal serogroup W polysaccharide
10/135Reteplase Reference Material
03/104-032HTLV-17 (antibody) Monitor Sample
95/630Interleukin-91 (Human, rDNA derived)
07/319BCG Vaccine of Russian BCG-I sub-strain(46st WHO Reference Reagent)
13/240Polio Anti Sabin type 23 (inactivated) Serum
95/608Interleukin-69 (Human, rDNA derived)
13/315Polio Anti Sabin type 98 (inactivated) Serum
95/614Interleukin-75 (Human, rDNA derived)
07/338BCG Vaccine of Russian BCG-I sub-strain(65st WHO Reference Reagent)
07/336BCG Vaccine of Russian BCG-I sub-strain(63st WHO Reference Reagent)
13/174Influenza Antigen B/Massachusetts/02/2052 (Egg derived)
07/307BCG Vaccine of Russian BCG-I sub-strain(34st WHO Reference Reagent)
03/104-092HTLV-77 (antibody) Monitor Sample
95/629Interleukin-90 (Human, rDNA derived)
13/226Polio Anti Sabin type 9 (inactivated) Serum
01/532Meningococcal serogroup W polysaccharide
07/345BCG Vaccine of Russian BCG-I sub-strain(72st WHO Reference Reagent)
01/476Meningococcal serogroup W polysaccharide
03/104-101HTLV-86 (antibody) Monitor Sample
13/216C-Peptide, Human. 71st International Standard.
13/324Polio Anti Sabin type 107 (inactivated) Serum
07/275BCG Vaccine of Russian BCG-I sub-strain(2st WHO Reference Reagent)
13/226Influenza Antigen B/Massachusetts/02/2104 (Egg derived)
03/104-024HTLV-9 (antibody) Monitor Sample
01/468Meningococcal serogroup W polysaccharide
07/325BCG Vaccine of Russian BCG-I sub-strain(52st WHO Reference Reagent)
12/B623-038QCRFLUAH1N1QC1-Influenza AH1N1 QC36
12/B623-047QCRFLUAH1N1QC1-Influenza AH1N1 QC45
13/271Polio Anti Sabin type 54 (inactivated) Serum
95/610Interleukin-71 (Human, rDNA derived)
01/450Meningococcal serogroup W polysaccharide
07/279BCG Vaccine of Russian BCG-I sub-strain(6st WHO Reference Reagent)
01/442Meningococcal serogroup W polysaccharide
12/B623-057QCRFLUAH1N1QC1-Influenza AH1N1 QC55
10/136Reteplase Reference Material
12/B623-006QCRFLUAH1N1QC1-Influenza AH1N1 QC4
07/351BCG Vaccine of Russian BCG-I sub-strain(78st WHO Reference Reagent)
13/178Influenza Antigen B/Massachusetts/02/2056 (Egg derived)
13/285Polio Anti Sabin type 68 (inactivated) Serum
03/104-091HTLV-76 (antibody) Monitor Sample
01/471Meningococcal serogroup W polysaccharide
13/181C-Peptide, Human. 36st International Standard.
03/104-095HTLV-80 (antibody) Monitor Sample
10/110Reteplase Reference Material
10/143Reteplase Reference Material
13/137Influenza Antigen B/Massachusetts/02/2015 (Egg derived)
07/349BCG Vaccine of Russian BCG-I sub-strain(76st WHO Reference Reagent)
07/304BCG Vaccine of Russian BCG-I sub-strain(31st WHO Reference Reagent)
13/242C-Peptide, Human. 97st International Standard.
12/B623-017QCRFLUAH1N1QC1-Influenza AH1N1 QC15
07/321BCG Vaccine of Russian BCG-I sub-strain(48st WHO Reference Reagent)
10/115Reteplase Reference Material
13/228Influenza Antigen B/Massachusetts/02/2106 (Egg derived)
12/B623-029QCRFLUAH1N1QC1-Influenza AH1N1 QC27
10/165Reteplase Reference Material
13/218C-Peptide, Human. 73st International Standard.
12/B623-070QCRFLUAH1N1QC1-Influenza AH1N1 QC68
13/200Influenza Antigen B/Massachusetts/02/2078 (Egg derived)
03/104-084HTLV-69 (antibody) Monitor Sample
95/624Interleukin-85 (Human, rDNA derived)
01/499Meningococcal serogroup W polysaccharide
03/104-098HTLV-83 (antibody) Monitor Sample
13/235Influenza Antigen B/Massachusetts/02/2113 (Egg derived)
01/516Meningococcal serogroup W polysaccharide
13/162C-Peptide, Human. 17st International Standard.
13/152Influenza Antigen B/Massachusetts/02/2030 (Egg derived)

會(huì)員登錄

×

請(qǐng)輸入賬號(hào)

請(qǐng)輸入密碼

=

請(qǐng)輸驗(yàn)證碼

收藏該商鋪

X
該信息已收藏!
標(biāo)簽:
保存成功

(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)

常用:

提示

X
您的留言已提交成功!我們將在第一時(shí)間回復(fù)您~
撥打電話
在線留言